Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older.
OBJECTIVE:We sought to examine whether the effect of treatment modality and drugs for cerebral vasospasm on clinical outcomes differs between elderly and non-elderly subarachnoid hemorrhage (SAH) patients in Japan. METHODS:We analyzed the J-ASPECT Study Diagnosis Procedure Combination database (n =...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0230953 |
id |
doaj-6e1365c586f34005b3807369c1e20ee5 |
---|---|
record_format |
Article |
spelling |
doaj-6e1365c586f34005b3807369c1e20ee52021-03-03T21:39:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01154e023095310.1371/journal.pone.0230953Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older.Keisuke IdoRyota KurogiAi KurogiKunihiro NishimuraKoichi ArimuraAtaru NishimuraNice RenAkiko KadaRyu MatsuoDaisuke OnozukaAkihito HagiharaSo TakagishiKeitaro YamagamiMisa TakegamiYasunobu NoharaNaoki NakashimaMasahiro KamouchiIsao DateTakanari KitazonoKoji IiharaJ-ASPECT Study CollaboratorsOBJECTIVE:We sought to examine whether the effect of treatment modality and drugs for cerebral vasospasm on clinical outcomes differs between elderly and non-elderly subarachnoid hemorrhage (SAH) patients in Japan. METHODS:We analyzed the J-ASPECT Study Diagnosis Procedure Combination database (n = 17,343) that underwent clipping or coiling between 2010 and 2014 in 579 hospitals. We stratified patients into two groups according to their age (elderly [≥75 years old], n = 3,885; non-elderly, n = 13,458). We analyzed the effect of treatment modality and anti-vasospasm agents (fasudil hydrochloride, ozagrel sodium, cilostazol, statin, eicosapentaenoic acid [EPA], and edaravone) on in-hospital poor outcomes (mRS 3-6 at discharge) and mortality using multivariable analysis. RESULTS:The elderly patients were more likely to be female, have impaired levels of consciousness and comorbidity, and less likely to be treated with clipping and anti-vasospasm agents, except for ozagrel sodium and statin. In-hospital mortality and poor outcomes were higher in the elderly (15.8% vs. 8.5%, 71.7% vs. 36.5%). Coiling was associated with higher mortality (odds ratio 1.43, 95% confidence interval 1.2-1.7) despite a lower proportion of poor outcomes (0.84, 0.75-0.94) in the non-elderly, in contrast to no effect on clinical outcomes in the elderly. A comparable effect of anti-vasospasm agents on mortality was observed between non-elderly and elderly for fasudil hydrochloride (non-elderly: 0.20, 0.17-0.24), statin (0.63, 0.50-0.79), ozagrel sodium (0.72, 0.60-0.86), and cilostazol (0.63, 0.51-0.77). Poor outcomes were inversely associated with fasudil hydrochloride (0.59, 0.51-0.68), statin (0.84, 0.75-0.94), and EPA (0.83, 0.72-0.94) use in the non-elderly. No effect of these agents on poor outcomes was observed in the elderly. CONCLUSIONS:In contrast to the non-elderly, no effect of treatment modality on clinical outcomes were observed in the elderly. A comparable effect of anti-vasospasm agents was observed on mortality, but not on functional outcomes, between the non-elderly and elderly.https://doi.org/10.1371/journal.pone.0230953 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Keisuke Ido Ryota Kurogi Ai Kurogi Kunihiro Nishimura Koichi Arimura Ataru Nishimura Nice Ren Akiko Kada Ryu Matsuo Daisuke Onozuka Akihito Hagihara So Takagishi Keitaro Yamagami Misa Takegami Yasunobu Nohara Naoki Nakashima Masahiro Kamouchi Isao Date Takanari Kitazono Koji Iihara J-ASPECT Study Collaborators |
spellingShingle |
Keisuke Ido Ryota Kurogi Ai Kurogi Kunihiro Nishimura Koichi Arimura Ataru Nishimura Nice Ren Akiko Kada Ryu Matsuo Daisuke Onozuka Akihito Hagihara So Takagishi Keitaro Yamagami Misa Takegami Yasunobu Nohara Naoki Nakashima Masahiro Kamouchi Isao Date Takanari Kitazono Koji Iihara J-ASPECT Study Collaborators Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. PLoS ONE |
author_facet |
Keisuke Ido Ryota Kurogi Ai Kurogi Kunihiro Nishimura Koichi Arimura Ataru Nishimura Nice Ren Akiko Kada Ryu Matsuo Daisuke Onozuka Akihito Hagihara So Takagishi Keitaro Yamagami Misa Takegami Yasunobu Nohara Naoki Nakashima Masahiro Kamouchi Isao Date Takanari Kitazono Koji Iihara J-ASPECT Study Collaborators |
author_sort |
Keisuke Ido |
title |
Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. |
title_short |
Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. |
title_full |
Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. |
title_fullStr |
Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. |
title_full_unstemmed |
Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. |
title_sort |
effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2020-01-01 |
description |
OBJECTIVE:We sought to examine whether the effect of treatment modality and drugs for cerebral vasospasm on clinical outcomes differs between elderly and non-elderly subarachnoid hemorrhage (SAH) patients in Japan. METHODS:We analyzed the J-ASPECT Study Diagnosis Procedure Combination database (n = 17,343) that underwent clipping or coiling between 2010 and 2014 in 579 hospitals. We stratified patients into two groups according to their age (elderly [≥75 years old], n = 3,885; non-elderly, n = 13,458). We analyzed the effect of treatment modality and anti-vasospasm agents (fasudil hydrochloride, ozagrel sodium, cilostazol, statin, eicosapentaenoic acid [EPA], and edaravone) on in-hospital poor outcomes (mRS 3-6 at discharge) and mortality using multivariable analysis. RESULTS:The elderly patients were more likely to be female, have impaired levels of consciousness and comorbidity, and less likely to be treated with clipping and anti-vasospasm agents, except for ozagrel sodium and statin. In-hospital mortality and poor outcomes were higher in the elderly (15.8% vs. 8.5%, 71.7% vs. 36.5%). Coiling was associated with higher mortality (odds ratio 1.43, 95% confidence interval 1.2-1.7) despite a lower proportion of poor outcomes (0.84, 0.75-0.94) in the non-elderly, in contrast to no effect on clinical outcomes in the elderly. A comparable effect of anti-vasospasm agents on mortality was observed between non-elderly and elderly for fasudil hydrochloride (non-elderly: 0.20, 0.17-0.24), statin (0.63, 0.50-0.79), ozagrel sodium (0.72, 0.60-0.86), and cilostazol (0.63, 0.51-0.77). Poor outcomes were inversely associated with fasudil hydrochloride (0.59, 0.51-0.68), statin (0.84, 0.75-0.94), and EPA (0.83, 0.72-0.94) use in the non-elderly. No effect of these agents on poor outcomes was observed in the elderly. CONCLUSIONS:In contrast to the non-elderly, no effect of treatment modality on clinical outcomes were observed in the elderly. A comparable effect of anti-vasospasm agents was observed on mortality, but not on functional outcomes, between the non-elderly and elderly. |
url |
https://doi.org/10.1371/journal.pone.0230953 |
work_keys_str_mv |
AT keisukeido effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT ryotakurogi effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT aikurogi effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT kunihironishimura effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT koichiarimura effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT atarunishimura effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT niceren effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT akikokada effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT ryumatsuo effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT daisukeonozuka effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT akihitohagihara effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT sotakagishi effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT keitaroyamagami effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT misatakegami effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT yasunobunohara effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT naokinakashima effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT masahirokamouchi effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT isaodate effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT takanarikitazono effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT kojiiihara effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder AT jaspectstudycollaborators effectoftreatmentmodalityandcerebralvasospasmagentonpatientoutcomesafteraneurysmalsubarachnoidhemorrhageintheelderlyaged75yearsandolder |
_version_ |
1714815773132718080 |